Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1) - PubMed (original) (raw)
. 1999 Feb 12;274(7):4115-23.
doi: 10.1074/jbc.274.7.4115.
Affiliations
- PMID: 9933605
- DOI: 10.1074/jbc.274.7.4115
Free article
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1)
P D Kwong et al. J Biol Chem. 1999.
Free article
Abstract
The extensive glycosylation and conformational mobility of gp120, the envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1), pose formidable barriers for crystallization. To surmount these difficulties, we used probability analysis to determine the most effective crystallization approach and derive equations which show that a strategy, which we term variational crystallization, substantially enhances the overall probability of crystallization for gp120. Variational crystallization focuses on protein modification as opposed to crystallization screening. Multiple variants of gp120 were analyzed with an iterative cycle involving a limited set of crystallization conditions and biochemical feedback on protease sensitivity, glycosylation status, and monoclonal antibody binding. Sources of likely conformational heterogeneity such as N-linked carbohydrates, flexible or mobile N and C termini, and variable internal loops were reduced or eliminated, and ligands such as CD4 and antigen-binding fragments (Fabs) of monoclonal antibodies were used to restrict conformational mobility as well as to alter the crystallization surface. Through successive cycles of manipulation involving 18 different variants, we succeeded in growing six different types of gp120 crystals. One of these, a ternary complex composed of gp120, its receptor CD4, and the Fab of the human neutralizing monoclonal antibody 17b, diffracts to a minimum Bragg spacing of at least 2.2 A and is suitable for structural analysis.
Similar articles
- CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.
Sullivan N, Sun Y, Sattentau Q, Thali M, Wu D, Denisova G, Gershoni J, Robinson J, Moore J, Sodroski J. Sullivan N, et al. J Virol. 1998 Jun;72(6):4694-703. doi: 10.1128/JVI.72.6.4694-4703.1998. J Virol. 1998. PMID: 9573233 Free PMC article. - Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article. - Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. Wyatt R, et al. J Virol. 1995 Sep;69(9):5723-33. doi: 10.1128/JVI.69.9.5723-5733.1995. J Virol. 1995. PMID: 7543586 Free PMC article. - HIV gp120: double lock strategy foils host defences.
Sattentau QJ. Sattentau QJ. Structure. 1998 Aug 15;6(8):945-9. doi: 10.1016/s0969-2126(98)00096-3. Structure. 1998. PMID: 9739096 Review. - Generative models of conformational dynamics.
Langmead CJ. Langmead CJ. Adv Exp Med Biol. 2014;805:87-105. doi: 10.1007/978-3-319-02970-2_4. Adv Exp Med Biol. 2014. PMID: 24446358 Free PMC article. Review.
Cited by
- Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
Aljedani SS, Liban TJ, Tran K, Phad G, Singh S, Dubrovskaya V, Pushparaj P, Martinez-Murillo P, Rodarte J, Mileant A, Mangala Prasad V, Kinzelman R, O'Dell S, Mascola JR, Lee KK, Karlsson Hedestam GB, Wyatt RT, Pancera M. Aljedani SS, et al. PLoS Pathog. 2021 Sep 24;17(9):e1009543. doi: 10.1371/journal.ppat.1009543. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34559844 Free PMC article. - A perspective on the PDB's impact on the field of glycobiology.
Prestegard JH. Prestegard JH. J Biol Chem. 2021 Jan-Jun;296:100556. doi: 10.1016/j.jbc.2021.100556. Epub 2021 Mar 18. J Biol Chem. 2021. PMID: 33744289 Free PMC article. Review. - Structure and Immune Recognition of the HIV Glycan Shield.
Crispin M, Ward AB, Wilson IA. Crispin M, et al. Annu Rev Biophys. 2018 May 20;47:499-523. doi: 10.1146/annurev-biophys-060414-034156. Epub 2018 Mar 29. Annu Rev Biophys. 2018. PMID: 29595997 Free PMC article. - The "Sticky Patch" Model of Crystallization and Modification of Proteins for Enhanced Crystallizability.
Derewenda ZS, Godzik A. Derewenda ZS, et al. Methods Mol Biol. 2017;1607:77-115. doi: 10.1007/978-1-4939-7000-1_4. Methods Mol Biol. 2017. PMID: 28573570 Free PMC article. Review. - A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4.
Duan LW, Zhang H, Zhao MT, Sun JX, Chen WL, Lin JP, Liu XQ. Duan LW, et al. Sci Rep. 2017 Apr 21;7:46733. doi: 10.1038/srep46733. Sci Rep. 2017. PMID: 28429756 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials